Nachrichten zur Hims & Hers Health Aktie

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after the bell. Here’s what to expect.…

Telehealth company Hims & Hers Health NYSE:HIMS will be reporting results this Monday after the bell. Here’s what to expect.Hims…

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after the bell. Here’s what to expect.…

Hims & Hers Health shares rose 10.2% to $28.27 on Friday ahead of first-quarter results due Monday.…

On May 08, 2026, Hims & Hers Health Inc (HIMS) shares rose 10.2% today, closing at $28.27. The stock has…

On May 08, 2026, Hims & Hers Health Inc (HIMS) is set to release its Q1 earnings on May 11th,…

Hims & Hers Health (HIMS) is scheduled to announce Q1 earnings results on Monday, May 11th, after market close. The…

Hims & Hers Health shares jumped 9.3% to $28.03 Friday as options traders bet on a 14.8% swing after next…

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

On Monday, May 11, Hims Hers Health ($HIMS), Circle ($CRCL), and Quantum Computing ($QUBT) will report their earnings. Circle will…

As Hims & Hers pivots to branded GLP-1s via a Novo Nordisk deal, all eyes are on the company’s May…

The AI agent will assess patients biomarkers from lab tests, identifying concerning patterns and providing insights into users health.…

The FDAs latest proposal would be a win for Eli Lilly and Novo Nordisk, while Hims & Hers Health would…

Hims & Hers launched an artificial intelligence agent embedded in its platform to help interpret biomarker lab results and provide…

Labs AI is an AI care agent embedded in the Hims & Hers platform that makes customers’ lab results clearer,…

Hims & Hers Health trades at $26.88 today, up 2.09%. Get the latest price action and momentum update for HIMS…

Wall Street expects a sharp earnings deceleration for Hims & Hers Health when the telehealth and direct-to-consumer pharmaceutical company reports…

Hims & Hers Health trades at $26.33 today, down 3.45%. Get the latest technical outlook and short-term range expectations.…

A recent StockStory analysis of three stocks under $50 recommends buying Hims & Hers Health for its 29.5% customer growth…

Wondering whether Hims & Hers Health at US$26.33 still offers value, or if the best entry points are already behind…

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…